Forty Seven, Inc.

Patents = 15

Trademarks = 3

Forward Citations = 20

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

25 inventors (with patents filed for the assignee):

Forty Seven, Inc. is a clinical-stage immuno-oncology company focused on developing therapies to activate macrophages to fight cancer. Their lead product candidate, 5F9, is being evaluated in multiple clinical trials for various types of cancer. The company is dedicated to advancing the field of immuno-oncology and improving outcomes for cancer patients.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com